Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Ritonavir Recommended by China's NHC Guidelines Used to treat other disease Antiviral Dec/09/2020 21 11
Darunavir Potential treatment - clinical evidence Used to treat other disease Antiviral Nov/26/2020 5 1
Lopinavir Recommended by China's NHC Guidelines Used to treat other disease Antiviral Nov/26/2020 22 11
Favipiravir Approved for COVID-19 treatment (China, India, Russia) Used to treat other disease Antiviral Nov/25/2020 19 5
Camostat mesylate Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Nov/06/2020 7 0
Leronlimab Potential treatment - clinical evidence Used to treat other disease Other treatment Oct/20/2020 2 0
Bromhexine hydrochloride Potential treatment - clinical evidence Used to treat other disease Antiviral Sep/03/2020 3 0
Cobicistat Potential treatment - clinical evidence Used to treat other disease Other treatment Aug/27/2020 2 0
Alpha 1 antitrypsin Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jul/02/2020 2 0
4-(2-aminomethyl)benzenesulfonyl fluoride Potential treatment - pre-clinical evidence Used to treat other disease Antiviral May/05/2020 1 0